Epidemiological Status of Thyroid Eye Disease in Central Iran

被引:3
|
作者
Eshraghi, Bahram [1 ]
Nikdel, Mojgan
Abbasi, Maryam [1 ]
机构
[1] Isfahan Univ Med Sci, Isfahan Eye Res Ctr, Dept Ophthalmol, Esfahan, Iran
来源
JOURNAL OF CURRENT OPHTHALMOLOGY | 2022年 / 34卷 / 01期
关键词
Graves' disease; Proptosis; Thyroid eye disease; Thyroid orbitopathy; Thyroid-associated ophthalmopathy; GRAVES OPHTHALMOPATHY; EUROPEAN GROUP; ORBITOPATHY; MANAGEMENT; SEVERITY; PATHOGENESIS; PREVALENCE; CRITERIA; UPDATE; AGE;
D O I
10.4103/joco.joco_223_21
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To focus on clinical manifestations and epidemiology of thyroid eye disease (TED) in Central Iran's population. Methods: In this retrospective case study, we analyzed all patients with TED who were referred to our oculoplastic clinic from 2015 to 2019. The patients' epidemiological characteristics and clinical presentation were compared between different thyroid disease groups and genders. Results: Overall, 383 patients (155 male; 40.5% and 228 female; 59.5%) were included. The mean age was 39.55 years (standard deviation +/- 13.45, range 10-72). Most patients (89%) were hyperthyroid with the highest duration of ocular involvement among all categories (25.6 months). The most common signs on ophthalmic examinations were proptosis (80.4%), followed by eyelid retraction (72.3.0%). TED was classified as mild in 24.5%, moderate to severe in 67.6%, and sight-threatening in 7.9%. Thirty patients (7.8%) had active TED. Conclusions: This series with a relatively more significant number of TED cases in Central Iran found similar epidemiological and clinical characteristics of TED compared to other studies from Iran. Most of our patients were hyperthyroid, with more females compared to males. Proptosis and eyelid retraction were the most common manifestations. Most TED patients were classified as moderate to severe.
引用
收藏
页码:106 / 111
页数:6
相关论文
共 50 条
  • [1] The epidemiological characteristics of patients with thyroid eye disease in a referral center in northern Iran
    Medghalchi, Abdolreza
    Akbari, Mitra
    Alizadeh, Yousef
    Moghadam, Reza Soltani
    [J]. JOURNAL OF CURRENT OPHTHALMOLOGY, 2018, 30 (04): : 353 - 358
  • [2] Implementation of thyroid eye disease registry in Iran: rationale and research protocol
    Shadi Akbarian
    Abbas Sheikhtaheri
    Farid Khorrami
    Hossein Ghahvechian
    Nasser Karimi
    Mohsen Bahmani Kashkouli
    [J]. Orphanet Journal of Rare Diseases, 19
  • [3] Implementation of thyroid eye disease registry in Iran: rationale and research protocol
    Akbarian, Shadi
    Sheikhtaheri, Abbas
    Khorrami, Farid
    Ghahvechian, Hossein
    Karimi, Nasser
    Kashkouli, Mohsen Bahmani
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2024, 19 (01)
  • [4] Thyroid eye disease
    Char, DH
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 1996, 80 (10) : 922 - 926
  • [5] Thyroid eye disease
    Wayne Todd Cornblath
    [J]. Current Treatment Options in Neurology, 2000, 2 (5) : 401 - 405
  • [6] Thyroid eye disease
    Perros, Petros
    Neoh, Christopher
    Dickinson, Jane
    [J]. BRITISH MEDICAL JOURNAL, 2009, 338 : 645 - 650
  • [7] Thyroid Eye Disease
    Cockerham, Kimberly P.
    Chan, Stephanie S.
    [J]. NEUROLOGIC CLINICS, 2010, 28 (03) : 729 - +
  • [8] THYROID EYE DISEASE
    ELSTON, JS
    [J]. EYE, 1990, 4 : R7 - R7
  • [9] THYROID EYE DISEASE
    CLIFTONBLIGH, P
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF OPHTHALMOLOGY, 1990, 18 (03): : 233 - 235
  • [10] Thyroid Eye Disease
    Rashad, Ramy
    Pinto, Raquel
    Li, Emily
    Sohrab, Mahsa
    Distefano, Alberto G.
    [J]. LIFE-BASEL, 2022, 12 (12):